Phase III Comparative Study(Open-Label) of MRA for Rheumatoid Arthritis(RA)

Status:
Completed

Trial end date:
2006-02-01

Target enrollment:

Participant gender:

To evaluate clinical efficacy and tolerability of MRA, patients with RA are randomized to receive either MRA or conventional DMARDs.

Phase 3

Chugai Pharmaceutical